Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia

被引:39
|
作者
Liu, Dongping [2 ]
He, Qingjuan [2 ,3 ]
Liu, Caigang [1 ]
机构
[1] China Medial Univ, Affiliated Hosp 1, Dept Oncol, Breast Surg Ward, Shenyang 110001, Liaoning, Peoples R China
[2] China Medial Univ, Affiliated Hosp 1, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
[3] Eighth Peoples Hosp Qindao, Dept Gastroenterol, Shenyang 110001, Liaoning, Peoples R China
关键词
cyclooxygenase-2; dysplasia; Helicobacter pylori; intestinal metaplasia; vascular endothelial growth factor; CANCER; PATHWAY; ASSOCIATION;
D O I
10.1111/j.1440-1746.2009.06168.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: To examine the rate of Helicobacter pylori infection and the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in gastric mucosa with intestinal metaplasia or dysplasia, and explore their correlations in precancerous gastric lesions. Methods: A total of 172 patients were included in the study. H. pylori infection was evaluated by hematoxylin-eosin and modified Giemsa staining. The expression of COX-2 and VEGF proteins was detected by immunohistochemistry. Results: The rates of H. pylori infection in gastric mucosal dysplasia (DYS), intestinal metaplasia in gastric mucosa (IM), chronic atrophic gastritis (CAG) and chronic superficial gastritis (CSG) patients were significant differences (P = 0.001). The average optical density (AOD) values of COX-2 staining in CSG, CAG, IM and DYS patients were 13.81 +/- 5.53, 45.28 +/- 21.44, 73.67 +/- 26.02 and 91.23 +/- 45.11, respectively, with significant differences among CSG, CAG and IM patients (P = 0.037, 0.001 and 0.047 for CSG vs CAG, CSG vs IM and CAG vs IM, respectively). The expression level of VEGF in DYS patients was significantly higher than those in other patients (P = 0.001, 0.001 and 0.001 for DYS vs CSG, DYS vs CAG and DYS vs IM, respectively). The expression levels of COX-2 in H. pylori-positive IM, CAG and DYS patients were significantly higher than those in H. pylori-negative counterparts (P = 0.043, 0.009, 0.001, respectively). Additionally, the expression level of COX-2 was positively correlated with that of VEGF with the aggravation of gastric mucosal lesions (r = 0.640, P = 0.006). Conclusion: H. pylori infection might be able to induce the expression of COX-2 in precancerous gastric lesions, which in turn upregulates the expression of VEGF.
引用
收藏
页码:795 / 799
页数:5
相关论文
共 50 条
  • [31] Effect of mannitol on Helicobacter pylori-induced cyclooxygenase-2 expression in gastric epithelial AGS cells
    Kim, HY
    Seo, JY
    Kim, KH
    PHARMACOLOGY, 2002, 66 (04) : 182 - 189
  • [32] Expressions of cyclooxygenase-2 and vascular endothelial growth factor in colorectal adenoma
    Park, S
    Uetake, H
    Sugihara, K
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S107 - S107
  • [33] Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
    De Re, Valli
    Orzes, Enrico
    Canzonieri, Vincenzo
    Maiero, Stefania
    Fornasarig, Mara
    Alessandrini, Lara
    Cervo, Silvia
    Steffan, Agostino
    Zanette, Giorgio
    Mazzon, Cinzia
    De Paoli, Paolo
    Cannizzaro, Renato
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
  • [34] Expressions of cyclooxygenase-2 and vascular endothelial growth factor in colorectal adenoma
    S. Park
    H. Uetake
    K. Sugihara
    Annals of Surgical Oncology, 2004, 11 : S107 - S107
  • [35] Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas
    Sugita, Yasuo
    Komatani, Hideki
    Ohshima, Koichi
    Shigemori, Minoru
    Nakashima, Akihiko
    ONCOLOGY REPORTS, 2007, 18 (03) : 617 - 622
  • [36] Cyclooxygenase-2 expression in endometrial cancer: Correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase
    Fujiwaki, R
    Iida, K
    Kanasaki, H
    Ozaki, T
    Hata, K
    Miyazaki, K
    HUMAN PATHOLOGY, 2002, 33 (02) : 213 - 219
  • [37] Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma
    Cui, Yong
    Dong, Chang
    Wu, Bing-Qun
    Duan, Xin-Chun
    Shi, Guan
    Gong, Min
    Wang, Tian-You
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (05) : C44 - C48
  • [38] Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors
    Li M.
    Qi S.-Y.
    Wang Y.
    Feng S.-X.
    Zhang B.-Z.
    Wang R.
    Archives of Gynecology and Obstetrics, 2005, 272 (1) : 48 - 52
  • [39] Association of different genotypes of helicobacter pylori with CDX2 expression in intestinal metaplasia and gastric cancer
    Liang, Li
    Zhang, Zhong
    Bo, Wei
    Zhang, Min
    Wang, Xuguang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11666 - 11674
  • [40] Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma
    Kwon, Soon Ha
    Jeong, Soung Won
    Jang, Jae Young
    Lee, Ji Eun
    Lee, Sae Hwan
    Kim, Sang Gyune
    Kim, Young Seok
    Cho, Young Deok
    Kim, Hong Soo
    Kim, Boo Sung
    Jin, So-Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2012, 18 (03) : 287 - 294